Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Hematology"
DOI: 10.1002/ajh.25448
Abstract: Immune checkpoint inhibitors (ICPis) are a novel class of immunotherapeutic agents that have revolutionized the treatment of cancer; however, these drugs can also cause a unique spectrum of autoimmune toxicity. Autoimmune hemolytic anemia (AIHA) is… read more here.
Keywords: immune checkpoint; checkpoint inhibitors; autoimmune hemolytic; hemolytic anemia ... See more keywords